Showing results (41-50 of 214) with videos related to
Sort By:
Pageof 22
Bone Marrow Transplantation|September 14, 2004
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectivesR Zeiser, H Bertz, A Spyridonidis, et al.Bone Marrow Transplantation|November 2, 2004
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcomeR Zeiser, B Deschler, H Bertz, et al.Bone Marrow Transplantation|January 12, 2010
Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantationU Denz, H Bertz, G Ihorst, et al.Bone Marrow Transplantation|October 6, 2015
Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantationM Waterhouse, I Bartsch, H Bertz, et al.Hematology and Cell Therapy|April 1, 1997
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with second primary malignanciesS Fetscher, J Finke, R Engelhardt, et al.Mycoses|August 26, 1998
[Aspergillus antigen detection: comparison of a new sandwich ELISA with the latex agglutination test in patients with histologically proven invasive aspergillosis]J Herrmann, A Gugel, H Freidank, et al.Journal of Cancer Research and Clinical Oncology|July 13, 2006
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcomaM Engelhardt, R Zeiser, G Ihorst, et al.Leukemia|February 1, 1997
Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effectH Bertz, J A Burger, R Kunzmann, et al.Bone Marrow Transplantation|January 23, 2008
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantationC Grüllich, H Bertz, A Spyridonidis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselectionM Engelhardt, H Bertz, M Afting, et al.Pageof 22